CLASS II ONGOING Device recall · Reported 10 Dec 2025 · FDA Enforcement Report

Hemochron Activated Clotting Time Low-Range Test Cuvette recalled

Accriva Diagnostics is recalling Hemochron Activated Clotting Time Low-Range Test Cuvette, distributed nationwide in the US. The recall was initiated on 5 Nov 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 10711234103081. Lot: E5JLR132. Expiration: 08-31-2026
Quantity recalled20250

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0880-2026
FDA event ID
97942
Recalling firm
Accriva Diagnostics, San Diego, CA
Classification
Class II
Status
Ongoing
Recall initiated
5 Nov 2025
FDA classified
3 Dec 2025
Reported
10 Dec 2025
Type
Voluntary: Firm initiated
Reason category
Foreign Material

Timeline

5 Nov 2025Recall initiated by company
3 Dec 2025Classified by FDA+28 days
10 Dec 2025Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Test cuvettes, used with an assay for monitoring heparin anticoagulation, may have a foreign object that has sharp edges and could pose a risk of injury if not detected prior to handling.

Foreign material recalls cover pieces of metal, plastic, glass, wood or other objects that got into the product during processing and could cause injury if eaten.

Product as listed by the FDA

Hemochron Activated Clotting Time Low-Range Test Cuvette, REF: ACT-LR, to be used with the Hemochron Signature ELITE Whole Blood Microcoagulation System

Where it was distributed

Worldwide - US Nationwide distribution including in the states of OH, IL, NY, GA, CA, IN, NJ, TX, KS, NE, FL, SC, MO, WV, WA, MI, CO, TN, PA, UT, LA, MT, NC, KY, TX and the countries of CA.

Nationwide CaliforniaColoradoFloridaGeorgiaIllinoisIndianaKansasKentuckyLouisianaMichiganMissouriMontanaNorth CarolinaNebraskaNew JerseyNew YorkPennsylvaniaSouth CarolinaTennesseeTexas

Questions about this recall

Why was it recalled?

Test cuvettes, used with an assay for monitoring heparin anticoagulation, may have a foreign object that has sharp edges and could pose a risk of injury if not detected prior to handling.

Which lots are affected?

UDI-DI: 10711234103081. Lot: E5JLR132. Expiration: 08-31-2026

Where was it sold?

Worldwide - US Nationwide distribution including in the states of OH, IL, NY, GA, CA, IN, NJ, TX, KS, NE, FL, SC, MO, WV, WA, MI, CO, TN, PA, UT, LA, MT, NC, KY, TX and the countries of CA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Accriva Diagnostics

All 6

Other Other Medical Devices recalls

All 13,968